Medication info
Micater Plus Tablet 80/25 mg

Micater Plus Tablet 80/25 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›25mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Oblong tablet consisting of two layers: white to yellow, with possible yellow specks on the white layer.
Packaging
30 tablets/box [(10 tablets/Alu-Alu)x3], 30 tablets/bottle
Approval status
Active

MFDS item code 201207594 · Approved 2012.10.31 · Insurance code 642904580

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medication, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately for the patient. When clinically appropriate, a direct switch from monotherapy to this medication may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg taken concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medication. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medication should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medication should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.
Child dose
The safety and efficacy of this medication have not been established in children under 18 years of age.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension, administered to patients whose blood pressure is inadequately controlled with either telmisartan 80 mg and hydrochlorothiazide 12.5 mg as a single or combination therapy. The two ingredients work together to effectively lower and control blood pressure, thereby helping to manage it steadily and contributing to reducing the risk of complications associated with hypertension.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medication, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately for the patient. When clinically appropriate, a direct switch from monotherapy to this medication may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg taken concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medication. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medication should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose should not exceed 40/12.5mg. This medication should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. Older adults No dose adjustment is necessary.

Child dose

The safety and efficacy of this medication have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause severe harm to the fetus or newborn; discontinuation should occur immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or excipients or those with specific liver or kidney diseases should not use this medication. Elderly patients or those with high potassium levels, liver impairment, or heart valve abnormalities must use this medication cautiously. This medication may have various side effects, including dizziness, diarrhea, cough, skin rashes, etc.; if any unusual symptoms occur, consult the healthcare professional immediately. Especially, as this medication lowers blood pressure, excessive hypotension can increase the risk of myocardial infarction or stroke, necessitating regular monitoring of blood pressure control. This medication can interact with other antihypertensives, diuretics, lithium, potassium supplements, and so should be communicated to the physician for careful co-administration. Pregnant or lactating women should not take this medication, and alternatives should be considered if planning for pregnancy. In the case of overdose, symptoms such as hypotension, electrolyte imbalance, and dehydration may occur, requiring immediate medical attention. Safety for children has not been established, and use is not recommended in individuals under 18 years of age. Store this medication out of reach of children, keeping it sealed until use, and do not transfer to another container.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
Show 119 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonitis
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • lower back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • weakness
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • erythema multiforme
  • acute renal failure
  • diabetes
  • asthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • proteinuria
  • pruritus
  • myalgia
  • floating sensation
  • lip and hand tremors
  • hypersensitivity
  • decreased vision
  • hypotension
  • tachycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps
  • cardiac arrhythmias
  • acute respiratory distress syndrome
  • pancreatitis
  • angioedema
  • acute renal failure
  • acute angle-closure glaucoma
  • yellow vision
  • acute myopia
  • choroidal exudate
  • dry lips
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air entry, at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Oblong tablet consisting of two layers: white to yellow, with possible yellow specks on the white layer.

Package unit

30 tablets/box [(10 tablets/Alu-Alu)x3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.